Rang	Name	Position
1	Dr. Albert Bourla D.V.M., Ph.D.	Chairman of the Board & CEO
2	Mr. David M. Denton	Executive VP & CFO
3	Dr. Chris Boshoff FMedSci, M.D., Ph.D.	Chief Scientific Officer and President of Research & Development
4	Mr. Douglas M. Lankler	Executive VP & Chief Legal Officer
5	Mr. Aamir Malik	Executive VP & Chief U.S. Commercial Officer
6	Ms. Jennifer B. Damico	Senior VP, Controller & Principal Accounting Officer
7	Mr. Dennis P. Hancock	Executive VP & Chief Information Officer
8	Ms. Francesca M. DeMartino	Chief Investor Relations Officer
9	Ms. Payal Sahni Becher	Chief People Experience Officer & Executive VP
10	Dr. Michael S. Vincent M.D., Ph.D.	Senior VP and Chief Scientific Officer of Inflammation & Immunology

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Group Inc	0,00%	0,00 Mio. USD
2	BlackRock Inc	0,00%	0,00 Mio. USD
3	Vanguard Capital Management, LLC	0,00%	0,00 Mio. USD
4	State Street Corp	0,00%	0,00 Mio. USD
5	Geode Capital Management, LLC	0,00%	0,00 Mio. USD
6	Vanguard Portfolio Management, LLC	0,00%	0,00 Mio. USD
7	Fisher Asset Management, LLC	0,00%	0,00 Mio. USD
8	Morgan Stanley - Brokerage Accounts	0,00%	0,00 Mio. USD
9	NORGES BANK	0,00%	0,00 Mio. USD
10	Northern Trust Corp	0,00%	0,00 Mio. USD
11	Massachusetts Financial Services Company	0,00%	0,00 Mio. USD
12	State Farm Mutual Automobile Ins Co	0,00%	0,00 Mio. USD
13	Bank of New York Mellon Corp	0,00%	0,00 Mio. USD
14	Charles Schwab Investment Management Inc	0,00%	0,00 Mio. USD
15	Wellington Management Company LLP	0,00%	0,00 Mio. USD
16	The Goldman Sachs Group Inc	0,00%	0,00 Mio. USD
17	Bank of America Corp	0,00%	0,00 Mio. USD
18	Legal & General Group PLC	0,00%	0,00 Mio. USD
19	Amundi	0,00%	0,00 Mio. USD
20	Dimensional Fund Advisors, Inc.	0,00%	0,00 Mio. USD